Right Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease (RaDICAL-CHD)
Primary Purpose
Pulmonary Regurgitation, Congenital Heart Disease
Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Acquisition of pressure-volume-loops
Sponsored by
About this trial
This is an interventional treatment trial for Pulmonary Regurgitation focused on measuring Congenital Heart Disease, pressure-volume loops, diastolic function
Eligibility Criteria
Inclusion Criteria:
- Patient with CHD involving the RV
- Chronic RV volume and/or pressure overload as defined by:
- more than mild pulmonary regurgitation and/or
- more than mild tricuspid regurgitation and/or
- a gradient across the RV outflow tract of ≥ 3 m/s on echocardiography and/or
- estimated RV systolic pressure > 65 mmHg
- Clinical indication for cardiac catheterization
- Age 12 to 80 years
- Informed consent
Exclusion Criteria:
- Contraindication for magnetic resonance imaging or cardiopulmonary exercise testing
- Pregnancy
- RV systolic function on magnetic resonance imaging < 45%
Sites / Locations
- Heart Center of the University Leipzig
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Acquisition of pressure-volume loops
Arm Description
Outcomes
Primary Outcome Measures
Presence of RV diastolic dysfunction in CHD and RVOT dysfunction
Determination of load-independent stiffness constant in CHD
Secondary Outcome Measures
Link between RV load-independent stiffness constant and functional capacity
Oxygen uptake (VO2 max) in correlation to load-independent stiffness constant
Association between E/É and RV stiffness in CHD
Correlation between E/É and load-independent stiffness constant
Association between RV stiffness expressed as E/É and functional outcome after surgical or percutaneous pulmonary valve replacement
Correlation between E/É before intervention and VO2 max change after pulmonary valve replacement
Full Information
NCT ID
NCT03471936
First Posted
February 1, 2018
Last Updated
May 6, 2021
Sponsor
Heart Center Leipzig - University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03471936
Brief Title
Right Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease
Acronym
RaDICAL-CHD
Official Title
Right Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 7, 2016 (Actual)
Primary Completion Date
August 2021 (Anticipated)
Study Completion Date
August 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Heart Center Leipzig - University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to assess the characteristics, incidence and predictors of load-independent right ventricle (RV) diastolic dysfunction in patients with congenital heart disease (CHD) and adverse RV loading conditions by acquiring pressure-volume loops and compare these results to a population of patients with exclusion of coronary artery disease and absence of any known disease affecting the RV.
Detailed Description
One of the major problems in the expanding population of patients with congenital heart disease (CHD) is dysfunction of the right ventricular (RV) outflow tract (OT). Initial surgical repair for complex conditions or repeated surgery for free pulmonary regurgitation often includes the creation of an artificial RV to main pulmonary artery connection. Over time, these conduits are prone to develop valvar incompetence or obstruction. There is clear evidence that pulmonary stenosis and pulmonary regurgitation are associated with exercise intolerance, arrhythmias and an increased risk of sudden death. Timely pulmonary valve replacement can halt and may reverse such unfavourable outcomes. However, this means that patients have to undergo multiple open-heart surgeries in order to reduce the haemodynamic burden on the right ventricle. Decision making in these patients with RVOT dysfunction is based on the aim to perform pulmonary valve replacement as late as possible to minimise the total number of open-heart surgeries required in individual patients, but before functional impairment might be irreversible. Importantly, this point of 'no return' in right ventricular pressure and/or volume overload is still unknown and represents one of the most challenging problems in the field of CHD. Ideally, quality of life, survival and freedom from atrial and ventricular arrhythmia should be the endpoints for any study trying to optimise timing of pulmonary valve replacement. However, such studies would require long follow-up in large patient populations and will not help to improve management of right ventricular outflow tract (RVOT) dysfunction in the short-term. In order to design studies with surrogate functional endpoints, a sound understanding of physiological consequences of altering RV loading and its implications for bi-ventricular function or exercise capacity is pivotal.
The investigators established a method of acquiring robust RV pressure-volume-loops at our institution. In the context of a research study, the investigators performed RV conductance catheter measurements in 22 patients with heart failure with preserved ejection fraction and in 11 patients with no evidence of any RV disease. Within the RaDICAL study the investigators aim further to compare these results to pressure-volume loops acquired in patients with congenital heart disease (CHD) and adverse RV loading conditions in order to evaluate characteristics, incidence and predictors of load-independent right ventricle (RV) diastolic dysfunction.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Regurgitation, Congenital Heart Disease
Keywords
Congenital Heart Disease, pressure-volume loops, diastolic function
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Acquisition of pressure-volume loops
Arm Type
Other
Intervention Type
Diagnostic Test
Intervention Name(s)
Acquisition of pressure-volume-loops
Intervention Description
Diagnostic workup including cardiac MRI, Echocardiography and cardiopulmonary exercise test (CPET) followed by invasive acquisition of RV and left ventricular (LV) pressure-volume-loops
Primary Outcome Measure Information:
Title
Presence of RV diastolic dysfunction in CHD and RVOT dysfunction
Description
Determination of load-independent stiffness constant in CHD
Time Frame
Baseline
Secondary Outcome Measure Information:
Title
Link between RV load-independent stiffness constant and functional capacity
Description
Oxygen uptake (VO2 max) in correlation to load-independent stiffness constant
Time Frame
Baseline
Title
Association between E/É and RV stiffness in CHD
Description
Correlation between E/É and load-independent stiffness constant
Time Frame
Baseline
Title
Association between RV stiffness expressed as E/É and functional outcome after surgical or percutaneous pulmonary valve replacement
Description
Correlation between E/É before intervention and VO2 max change after pulmonary valve replacement
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient with CHD involving the RV
Chronic RV volume and/or pressure overload as defined by:
more than mild pulmonary regurgitation and/or
more than mild tricuspid regurgitation and/or
a gradient across the RV outflow tract of ≥ 3 m/s on echocardiography and/or
estimated RV systolic pressure > 65 mmHg
Clinical indication for cardiac catheterization
Age 12 to 80 years
Informed consent
Exclusion Criteria:
Contraindication for magnetic resonance imaging or cardiopulmonary exercise testing
Pregnancy
RV systolic function on magnetic resonance imaging < 45%
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ingo Dähnert, MD
Organizational Affiliation
Head of pediatric cardiology, Heart Center Leipzig
Official's Role
Principal Investigator
Facility Information:
Facility Name
Heart Center of the University Leipzig
City
Leipzig
ZIP/Postal Code
04289
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
16039222
Citation
Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW. Right ventricular outflow tract reconstruction with an allograft conduit in non-ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg. 2005 Aug;80(2):655-63; discussion 663-4. doi: 10.1016/j.athoracsur.2005.02.053.
Results Reference
background
PubMed Identifier
16996925
Citation
Rastan AJ, Walther T, Daehnert I, Hambsch J, Mohr FW, Janousek J, Kostelka M. Bovine jugular vein conduit for right ventricular outflow tract reconstruction: evaluation of risk factors for mid-term outcome. Ann Thorac Surg. 2006 Oct;82(4):1308-15. doi: 10.1016/j.athoracsur.2006.04.071.
Results Reference
background
PubMed Identifier
9535436
Citation
Stark J, Bull C, Stajevic M, Jothi M, Elliott M, de Leval M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg. 1998 Mar;115(3):506-14; discussion 514-6. doi: 10.1016/S0022-5223(98)70312-5.
Results Reference
background
PubMed Identifier
11082375
Citation
Tweddell JS, Pelech AN, Frommelt PC, Mussatto KA, Wyman JD, Fedderly RT, Berger S, Frommelt MA, Lewis DA, Friedberg DZ, Thomas JP Jr, Sachdeva R, Litwin SB. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation. 2000 Nov 7;102(19 Suppl 3):III130-5. doi: 10.1161/01.cir.102.suppl_3.iii-130.
Results Reference
background
PubMed Identifier
11041398
Citation
Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-81. doi: 10.1016/S0140-6736(00)02714-8.
Results Reference
background
PubMed Identifier
1622697
Citation
Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN. Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation. Br Heart J. 1992 Jun;67(6):470-3. doi: 10.1136/hrt.67.6.470.
Results Reference
background
PubMed Identifier
19561027
Citation
Lurz P, Puranik R, Nordmeyer J, Muthurangu V, Hansen MS, Schievano S, Marek J, Bonhoeffer P, Taylor AM. Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J. 2009 Sep;30(18):2266-74. doi: 10.1093/eurheartj/ehp258. Epub 2009 Jun 26.
Results Reference
background
PubMed Identifier
25499392
Citation
Lurz P, Riede FT, Taylor AM, Wagner R, Nordmeyer J, Khambadkone S, Kinzel P, Derrick G, Schuler G, Bonhoeffer P, Giardini A, Daehnert I. Impact of percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction on exercise recovery kinetics. Int J Cardiol. 2014 Nov 15;177(1):276-80. doi: 10.1016/j.ijcard.2014.09.014. Epub 2014 Sep 22.
Results Reference
background
PubMed Identifier
19487596
Citation
Lurz P, Nordmeyer J, Muthurangu V, Khambadkone S, Derrick G, Yates R, Sury M, Bonhoeffer P, Taylor AM. Comparison of bare metal stenting and percutaneous pulmonary valve implantation for treatment of right ventricular outflow tract obstruction: use of an x-ray/magnetic resonance hybrid laboratory for acute physiological assessment. Circulation. 2009 Jun 16;119(23):2995-3001. doi: 10.1161/CIRCULATIONAHA.108.836312. Epub 2009 Jun 1.
Results Reference
background
PubMed Identifier
18391109
Citation
Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008 Apr 15;117(15):1964-72. doi: 10.1161/CIRCULATIONAHA.107.735779. Epub 2008 Apr 7.
Results Reference
background
PubMed Identifier
16014610
Citation
Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H501-12. doi: 10.1152/ajpheart.00138.2005.
Results Reference
background
PubMed Identifier
16769913
Citation
Dimopoulos K, Okonko DO, Diller GP, Broberg CS, Salukhe TV, Babu-Narayan SV, Li W, Uebing A, Bayne S, Wensel R, Piepoli MF, Poole-Wilson PA, Francis DP, Gatzoulis MA. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation. 2006 Jun 20;113(24):2796-802. doi: 10.1161/CIRCULATIONAHA.105.594218. Epub 2006 Jun 12.
Results Reference
background
Learn more about this trial
Right Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease
We'll reach out to this number within 24 hrs